← Back to Search

Cancer Episode Payment Model for Cancer Care

N/A
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the health outcomes and costs of care for cancer patients who receive chemotherapy under the HMSA Cancer Episode Payment Model (CEM) with those who receive care under the current fee-for-service model.

Who is the study for?
This trial is for oncologists in Hawaii who are part of the Hawaii Oncology network and treat HMSA members with lung, colorectal, breast, or colon cancer using chemotherapy. It's not open to providers outside this group.
What is being tested?
The trial is testing a new payment model called Cancer Episode Payment Model (CEM) that aims to improve care coordination for cancer patients undergoing chemotherapy and see if it can reduce healthcare costs while improving outcomes.
What are the potential side effects?
Since this trial involves a payment model rather than a medical intervention, there are no direct side effects like those associated with drugs or medical procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Composite quality score
Episode cost
Utilization of acute and specialty care
Secondary study objectives
Quality of care at end of life
Survival

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cancer Episode Payment ModelExperimental Treatment1 Intervention
Oncologists in this arm will be paid for each member's episode of care. The episode of care is 6 months in duration. Oncologists will have the opportunity to receive performance-based payments based upon a set of 6 quality metrics.
Group II: Fee for ServiceActive Control1 Intervention
Oncologists in this arm will not receive the intervention and will continue to be paid through fee-for-service.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,078 Previous Clinical Trials
42,721,378 Total Patients Enrolled
Hawaii Medical Service AssociationOTHER
3 Previous Clinical Trials
230 Total Patients Enrolled

Media Library

Cancer Episode Payment Model (CEM) Clinical Trial Eligibility Overview. Trial Name: NCT03523546 — N/A
Lung Cancer Research Study Groups: Cancer Episode Payment Model, Fee for Service
Lung Cancer Clinical Trial 2023: Cancer Episode Payment Model (CEM) Highlights & Side Effects. Trial Name: NCT03523546 — N/A
Cancer Episode Payment Model (CEM) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03523546 — N/A
~1 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top